Histomorphometric and microarchitectural analyses using the 2 mm bone marrow trephine in metastatic breast cancer patients–preliminary results

BACKGROUND: Bone-targeted agents are widely used for the treatment of osteoporosis, the prevention of cancer-therapy induced bone loss, and for reducing the risk of skeletal related events in patients with metastatic disease. Despite widespread use, relatively little is known about the in vivo effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Fralick, M., Bouganim, N., Kremer, R., Kekre, N., Robertson, S., Vandermeer, L., Kuchuk, I., Li, J., Murshed, M., Clemons, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723346/
https://www.ncbi.nlm.nih.gov/pubmed/26909259
http://dx.doi.org/10.1016/j.jbo.2012.10.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723346/
https://www.ncbi.nlm.nih.gov/pubmed/26909259
http://dx.doi.org/10.1016/j.jbo.2012.10.003

Ejemplares similares